A Multi-Center, Multinational, Observational Study of Octreotide Subcutaneous Depot for the Treatment of Patients With Acromegaly
Status: Recruiting
Location: See all (4) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Have started or will be starting treatment with octreotide SC depot for acromegaly
Locations
Other Locations
Germany
Universitaetsklinikum Aachen
NOT_YET_RECRUITING
Aachen
Universitaetsklinikum Leipzig
RECRUITING
Leipzig
Fachpraxis für Innere Medizin, Endokrinologie und Diabetologie
NOT_YET_RECRUITING
Magdeburg
Medicover Neuroendokrinologie MVZ
NOT_YET_RECRUITING
München
Contact Information
Primary
Camurus AB
medicalinfo@camurus.com
+46 46 286 57 30
Time Frame
Start Date: 2026-06-05
Estimated Completion Date: 2029-06
Participants
Target number of participants: 200
Related Therapeutic Areas
Sponsors
Leads: Camurus AB